Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade (Q44574646)

4 December 2017

1 reference

title

Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade (English)

1 reference

4 December 2017

Ernesto L Schiffrin

1

1 reference

PubMed ID

12957442

4 December 2017

Rhian M Touyz

series ordinal

2

1 reference

PubMed ID

12957442

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

1 reference

4 December 2017

42

1 reference

4 December 2017

5

1 reference

4 December 2017

911-913

1 reference

Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Blood pressure and inflammation in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Current concepts of the pathogenesis of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Novel clinical markers of vascular wall inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Soluble adhesion molecules and the search for biomarkers for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

NAD(P)H oxidase: role in cardiovascular biology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Reactive oxygen species: roles in blood pressure and kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Free radicals in the physiological control of cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Reactive oxygen species as intracellular messengers during cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

The neutrophil NADPH oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells :a potential atherogenic source of reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Superoxide production and expression of nox family proteins in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Vascular inflammation and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

Molecular mechanisms of angiotensin II-induced vascular injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900845-3

7 January 2021

10.1016/S0735-1097(03)00845-3

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12957442